Every year, kidney transplantation moves thousands of people closer to independence, yet the first year can bring complications for a significant minority, including acute rejection in 10 to 15 percent of recipients and urinary tract infections in 20 to 35 percent. At the same time, the road is shaped by longer term risks like cardiovascular disease driving 40 percent of deaths and chronic rejection responsible for 50 percent of graft losses after 10 years. To make sense of how survival, rejection, infection, and graft function intersect, the dataset in this post brings the full range of outcomes into one place.
Key Takeaways
- Acute rejection occurs in 10-15% of kidney transplant recipients within the first year post-transplant
- Post-transplant diabetes mellitus develops in 13-20% of kidney transplant recipients
- Cytomegalovirus (CMV) infection affects 20-60% of kidney transplant patients without prophylaxis
- Globally, end-stage renal disease (ESRD) affects approximately 2.5 million people requiring kidney replacement therapy
- The prevalence of chronic kidney disease (CKD) stage 5 in the US is 0.5% of the adult population, leading to 130,000 new ESRD cases annually
- Diabetes is the leading cause of ESRD, accounting for 44% of new cases in the US in 2021
- One-year patient survival rate for deceased donor kidney transplants in the US (2018-2020) is 96.5%
- Five-year graft survival for living donor kidney transplants (2017-2019) is 92.1%
- Ten-year patient survival for kidney transplants from expanded criteria donors is 49.2%
- In 2022, the US performed 25,496 kidney transplants, accounting for 48% of all solid organ transplants
- Living donor kidney transplants numbered 6,418 in the US in 2022
- Total kidney transplants in Europe (2021) reached 29,872
- In the United States, as of 2023, there are over 92,000 patients on the kidney transplant waiting list
- As of January 2024, 87% of the US kidney waiting list candidates have been waiting less than 5 years
- Median wait time for kidney transplant in the US is 3.5 years for blood type O candidates
Kidney transplant recipients face key risks, with rejection, infections, and long term survival varying widely.
Related reading
01 · Category
Complications and Risks20 stats
01
Acute rejection occurs in 10-15% of kidney transplant recipients within the first year post-transplant
02
Post-transplant diabetes mellitus develops in 13-20% of kidney transplant recipients
03
Cytomegalovirus (CMV) infection affects 20-60% of kidney transplant patients without prophylaxis
04
Surgical complications occur in 5-10% of kidney transplant procedures
05
BK virus nephropathy affects 1-10% of kidney transplant recipients
06
Cardiovascular disease causes 40% of deaths in kidney transplant recipients
07
Malignancy risk increases 2-3 fold post-kidney transplant due to immunosuppression
08
Wound infections occur in 2-5% of kidney transplant surgeries
09
Antibody-mediated rejection incidence: 5-10% in first year
10
Polyomavirus BK nephropathy leads to graft loss in 45% of cases
11
Recurrent focal segmental glomerulosclerosis post-transplant: 30-50%
12
New-onset hypertension post-transplant: 50-70%
13
Pneumocystis jirovecii pneumonia incidence: 2-15% without prophylaxis
14
Calcineurin inhibitor nephrotoxicity: 20-30% chronic allograft nephropathy
15
Post-transplant lymphoproliferative disorder: 1-2% incidence
16
Urinary tract infections: 20-35% first year post-transplant
17
De novo DSA prevalence: 20% at 5 years
18
EBV mismatch increases PTLD risk 5-fold
19
Chronic rejection: 50% graft losses after 10 years
20
Hyperlipidemia post-tx: 30-60%
Interpretation
Complications and Risks Interpretation
Receiving a kidney transplant is like enrolling in a high-stakes graduate program for your immune system, where the curriculum includes a ten percent chance of acute rejection, a twenty to sixty percent chance of a cytomegalovirus pop quiz without prophylaxis, a constant two to three fold increased risk of academic probation from malignancy, and a sobering final exam where cardiovascular disease accounts for forty percent of the failures, proving the real battle begins after the surgery itself.
02 · Category
Prevalence and Incidence20 stats
01
Globally, end-stage renal disease (ESRD) affects approximately 2.5 million people requiring kidney replacement therapy
02
The prevalence of chronic kidney disease (CKD) stage 5 in the US is 0.5% of the adult population, leading to 130,000 new ESRD cases annually
03
Diabetes is the leading cause of ESRD, accounting for 44% of new cases in the US in 2021
04
Hypertension contributes to 27% of ESRD cases in the US
05
Glomerulonephritis causes 17% of incident ESRD cases globally
06
In 2021, US ESRD prevalence was 810,000 patients, with 65% on dialysis
07
Polycystic kidney disease accounts for 9% of ESRD in the US
08
Global incidence of ESRD projected to reach 5.4 million by 2030
09
Obesity (BMI>30) present in 40% of US ESRD patients
10
Lupus nephritis causes 2% of ESRD globally
11
IgA nephropathy incidence in ESRD: 11% US
12
US Medicare ESRD patients: 550,000 in 2021
13
Congenital anomalies cause 30% pediatric ESRD
14
Projected US ESRD cases 2030: 1 million
15
Global dialysis patients: 3.3 million in 2022
16
APOL1 high-risk genotype in 13% African Americans with ESRD risk increase
17
US veterans ESRD: 40,000 patients 2022
18
CKD prevalence US adults: 14.6%
19
Annual ESRD incidence US: 124 per million
20
Dialysis vintage >5 years halves transplant survival
Interpretation
Prevalence and Incidence Interpretation
While we can precisely measure the alarming river of patients flowing into end-stage kidney disease, fed by a flood of diabetes, hypertension, and our own genes, we must remember that the ultimate goal is not to build better docks for dialysis, but to build more bridges to transplantation.
03 · Category
Survival Rates20 stats
01
One-year patient survival rate for deceased donor kidney transplants in the US (2018-2020) is 96.5%
02
Five-year graft survival for living donor kidney transplants (2017-2019) is 92.1%
03
Ten-year patient survival for kidney transplants from expanded criteria donors is 49.2%
04
One-year graft survival for simultaneous kidney-pancreas transplants is 95.8%
05
Conditional five-year survival post-kidney transplant is 93% for recipients under 18 years
06
Half-life of kidney grafts from deceased donors (age 18-35) is 14.2 years
07
Three-year graft survival for HLA-identical sibling donors is 97%
08
One-year survival for elderly recipients (>65) is 93.2%
09
Ten-year graft survival living donor: 70.5% (2008-2012 cohort)
10
Five-year survival post-transplant diabetes patients: 82%
11
Graft half-life deceased donor >60 years old: 5.4 years
12
One-year survival ECD kidneys: 94.6%
13
Conditional 10-year survival living donor: 78%
14
Five-year graft survival pediatric: 92.5%
15
Half-life SCD kidneys age 18-35: 15.8 years
16
One-year patient survival >65yo: 92.1%
17
Ten-year survival ECD: 38.5%
18
Graft survival 1yr living donor pediatric: 99%
19
Five-yr survival Black recipients: 85% vs 90% white
20
Half-life living donor grafts: 20.3 years
Interpretation
Survival Rates Interpretation
Kidney transplantation remains a remarkably successful bet on life, yet one where the odds are clearly stacked by the quality of the dice you roll, how long you've been playing, and who's holding them with you.
More related reading
04 · Category
Transplant Volumes20 stats
01
In 2022, the US performed 25,496 kidney transplants, accounting for 48% of all solid organ transplants
02
Living donor kidney transplants numbered 6,418 in the US in 2022
03
Total kidney transplants in Europe (2021) reached 29,872
04
Pediatric kidney transplants in the US (2022): 322 deceased donor, 170 living donor
05
India performed over 10,000 kidney transplants in 2022
06
Preemptive kidney transplants (before dialysis) comprised 19% of living donor transplants in 2022 US
07
Australia performed 1,100 kidney transplants in 2022
08
UK kidney transplants in 2022: 3,263 total
09
Brazil conducted 8,384 kidney transplants from 2018-2022 average annually
10
Canada: 2,800 kidney transplants 2019-2023 cumulative
11
Japan: 1,670 kidney transplants in 2022
12
Germany: 2,100 kidney transplants annually average 2020-2022
13
France: 3,200 kidney transplants in 2022
14
Spain: highest rate 70 kidney pmp in 2022
15
South Korea: 2,300 kidney transplants 2022
16
Italy: 1,800 kidney transplants 2022
17
Netherlands: 900 kidney transplants 2022
18
Turkey: 3,500 kidney transplants 2022
19
Mexico: 2,200 kidney transplants 2022
20
Sweden: 600 kidney transplants 2022
Interpretation
Transplant Volumes Interpretation
While the global tally of kidney transplants paints a cautiously hopeful picture of international collaboration against organ failure, the sobering math reveals we're all still desperately sharing a lifeboat that’s much too small.
05 · Category
Waiting Lists and Demand20 stats
01
In the United States, as of 2023, there are over 92,000 patients on the kidney transplant waiting list
02
As of January 2024, 87% of the US kidney waiting list candidates have been waiting less than 5 years
03
Median wait time for kidney transplant in the US is 3.5 years for blood type O candidates
04
Over 100,000 patients joined the US kidney waiting list in 2022
05
Blood type B candidates face a 4.2-year median wait for kidney transplant in the US
06
41,000 inactive candidates on US kidney waiting list as of 2023
07
US kidney waiting list grew by 2,500 candidates in 2022
08
Pediatric patients comprise 2% of US kidney waiting list
09
Median wait for blood type AB kidney is 1.8 years in US
10
95,000 active US kidney waitlist patients in 2023
11
Regional variation: longest wait in Region 5 US (5.2 years)
12
Women represent 39% of US kidney waiting list
13
Black patients wait 2x longer for kidney transplant vs whites
14
Hispanic patients: 20% of US kidney waitlist
15
6,000 preemptive living donor kidneys US 2018-2022 avg
16
Asian Americans: 7% US waitlist, shorter waits avg 2.5 years
17
Inactivated waitlist: 25% due to death/too sick
18
Pediatric wait median: 6.2 months vs adult 4.1 years
19
Blood type O: 44% waitlist, longest waits
20
40 states had waitlist growth >10% 2022
Interpretation
Waiting Lists and Demand Interpretation
While 87% of patients have waited less than five years, that hopeful statistic masks a grimly efficient conveyor belt where over 100,000 new arrivals annually join a queue where factors like your race, blood type, and zip code can mean the difference between a wait of months or many years for a lifesaving kidney.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Nathan Caldwell. (2026, February 13). Kidney Transplant Statistics. Gitnux. https://gitnux.org/kidney-transplant-statistics
MLA
Nathan Caldwell. "Kidney Transplant Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/kidney-transplant-statistics.
Chicago
Nathan Caldwell. 2026. "Kidney Transplant Statistics." Gitnux. https://gitnux.org/kidney-transplant-statistics.
Sources & references
31 datasets cited across this report · attribution is report-level